Please wait while the formulary information is being retrieved.
Drug overview for NYSTATIN (nystatin):
Generic name: NYSTATIN (NYE-stat-in)
Drug class: Mouth and Throat Antifungal Agents
Therapeutic class: Anti-Infective Agents
Nystatin, a polyene antibiotic, is an antifungal agent.
No enhanced Uses information available for this drug.
Generic name: NYSTATIN (NYE-stat-in)
Drug class: Mouth and Throat Antifungal Agents
Therapeutic class: Anti-Infective Agents
Nystatin, a polyene antibiotic, is an antifungal agent.
No enhanced Uses information available for this drug.
DRUG IMAGES
- NYSTATIN 500,000 UNIT ORAL TAB
The following indications for NYSTATIN (nystatin) have been approved by the FDA:
Indications:
Gastrointestinal candidiasis
Mucocutaneous candidiasis
Oral candidiasis
Professional Synonyms:
Candida infection of skin and mucous membranes
Candidiasis of intestine
Gastrointestinal moniliasis
Monilial stomatitis
Mucocutaneous moniliasis
Mycotic stomatitis
Oral candidosis
Oral cavity candidiasis
Oral moniliasis
Oral thrush
Indications:
Gastrointestinal candidiasis
Mucocutaneous candidiasis
Oral candidiasis
Professional Synonyms:
Candida infection of skin and mucous membranes
Candidiasis of intestine
Gastrointestinal moniliasis
Monilial stomatitis
Mucocutaneous moniliasis
Mycotic stomatitis
Oral candidosis
Oral cavity candidiasis
Oral moniliasis
Oral thrush
The following dosing information is available for NYSTATIN (nystatin):
Dosage of nystatin is expressed in terms of USP nystatin units.
Nystatin is applied topically to the skin as a cream, ointment, or powder. Nystatin also is commercially available in fixed combination with a corticosteroid (i.e., triamcinolone acetonide) for topical application to the skin as a cream or ointment. Nystatin is applied topically to the oral cavity as an oral suspension and is administered orally as film-coated tablets. Although nystatin has been administered intravaginally, intravaginal preparations of the drug are no longer commercially available in the US.
DRUG LABEL | DOSING TYPE | DOSING INSTRUCTIONS |
---|---|---|
NYSTATIN 500,000 UNIT ORAL TAB | Maintenance | Adults take 1 tablet (500,000 unit) by oral route 3 times per day continuing treatment for at least 2 days after symptoms have disappeared |
DRUG LABEL | DOSING TYPE | DOSING INSTRUCTIONS |
---|---|---|
NYSTATIN 500,000 UNIT ORAL TAB | Maintenance | Adults take 1 tablet (500,000 unit) by oral route 3 times per day continuingtreatment for at least 2 days after symptoms have disappeared |
The following drug interaction information is available for NYSTATIN (nystatin):
There are 0 contraindications.
There are 0 severe interactions.
There are 0 moderate interactions.
The following contraindication information is available for NYSTATIN (nystatin):
Drug contraindication overview.
No enhanced Contraindications information available for this drug.
No enhanced Contraindications information available for this drug.
There are 0 contraindications.
There are 0 severe contraindications.
There are 1 moderate contraindications.
Clinically significant contraindication, where the condition can be managed or treated before the drug may be given safely.
Moderate List |
---|
No disease contraindications |
The following adverse reaction information is available for NYSTATIN (nystatin):
Adverse reaction overview.
No enhanced Common Adverse Effects information available for this drug.
No enhanced Common Adverse Effects information available for this drug.
There are 4 severe adverse reactions.
More Frequent | Less Frequent |
---|---|
None. | None. |
Rare/Very Rare |
---|
Bronchospastic pulmonary disease Stevens-johnson syndrome Tachycardia Urticaria |
There are 8 less severe adverse reactions.
More Frequent | Less Frequent |
---|---|
None. |
Abdominal pain with cramps Diarrhea Gastrointestinal irritation Nausea Vomiting |
Rare/Very Rare |
---|
Facial edema Myalgia Skin rash |
The following precautions are available for NYSTATIN (nystatin):
No enhanced Pediatric Use information available for this drug.
Contraindicated
Severe Precaution
Management or Monitoring Precaution
Contraindicated
None |
Severe Precaution
None |
Management or Monitoring Precaution
None |
Animal reproduction studies have not been performed using topical or oral nystatin. It is not known whether nystatin can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Topical nystatin should be used during pregnancy only if potential benefits outweigh potential risks to the fetus.
Oral nystatin (oral suspension, tablets) should be used during pregnancy only if clearly needed. Fixed-combination topical preparations containing nystatin and triamcinolone acetonide should be used during pregnancy only if potential benefits outweigh potential risks to the fetus. Topical preparations containing corticosteroids should not be used extensively, in large amounts, or for prolonged periods during pregnancy.
Oral nystatin (oral suspension, tablets) should be used during pregnancy only if clearly needed. Fixed-combination topical preparations containing nystatin and triamcinolone acetonide should be used during pregnancy only if potential benefits outweigh potential risks to the fetus. Topical preparations containing corticosteroids should not be used extensively, in large amounts, or for prolonged periods during pregnancy.
It is not known whether nystatin is distributed into human milk. Nystatin and fixed combinations containing nystatin and triamcinolone acetonide should be used with caution in nursing women.
No enhanced Geriatric Use information available for this drug.
The following prioritized warning is available for NYSTATIN (nystatin):
No warning message for this drug.
No warning message for this drug.
The following icd codes are available for NYSTATIN (nystatin)'s list of indications:
Gastrointestinal candidiasis | |
B37.82 | Candidal enteritis |
Mucocutaneous candidiasis | |
B37.0 | Candidal stomatitis |
B37.2 | Candidiasis of skin and nail |
B37.3 | Candidiasis of vulva and vagina |
B37.31 | Acute candidiasis of vulva and vagina |
B37.32 | Chronic candidiasis of vulva and vagina |
B37.42 | Candidal balanitis |
B37.83 | Candidal cheilitis |
Oral candidiasis | |
B37.0 | Candidal stomatitis |
Formulary Reference Tool